- Home
- LFCR vs RMM Comparison
LFCR vs RMM Comparison
Compare LFCR & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.83
Company Overview
Basic Information| Metric | LFCR | RMM |
|---|---|---|
| Founded | 1986 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.0M | 276.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LFCR | RMM |
|---|---|---|
| Price | $7.83 | $14.14 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 171.0K | 66.5K |
| Earning Date | 01-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.96 |
| Revenue | ★ $128,867,000.00 | N/A |
| Revenue This Year | $2.80 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | ★ N/A | $15.55 |
| Revenue Growth | ★ 0.47 | N/A |
| 52 Week Low | $4.76 | $12.32 |
| 52 Week High | $8.85 | $16.10 |
Technical Indicators
Market Signals| Indicator | LFCR | RMM |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 67.83 |
| Support Level | $7.32 | $13.52 |
| Resistance Level | $8.43 | $13.74 |
| Average True Range (ATR) | 0.39 | 0.11 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 47.75 | 92.05 |
Price Performance
Historical Comparison LFCR
RMM
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.